Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.
Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E, Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F. Montalban X, et al. Among authors: liblau r. Eur J Neurol. 2018 Feb;25(2):215-237. doi: 10.1111/ene.13536. Epub 2018 Jan 19. Eur J Neurol. 2018. PMID: 29352526 Free article.
A systematic study of oligodendrocyte growth factors as candidates for genetic susceptibility to MS. French Multiple Sclerosis Genetics Group.
Mertens C, Brassat D, Reboul J, Eichenbaum-Voline S, Vuillemin-Azais C, Cournu I, Babron MC, Semana G, Edan G, Clanet M, Clerget-Darpoux F, Baron-Van Evercooren A, Lyon-Caen O, Liblau R, Fontaine B. Mertens C, et al. Among authors: liblau r. Neurology. 1998 Sep;51(3):748-53. doi: 10.1212/wnl.51.3.748. Neurology. 1998. PMID: 9748021
Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach. French Multiple Sclerosis Genetics Group.
Reboul J, Mertens C, Levillayer F, Eichenbaum-Voline S, Vilkoren T, Cournu I, Babron MC, Lyon-Caen O, Clerget-Darpoux F, Edan G, Clanet M, Brahic M, Bureau JF, Fontaine B, Liblau R. Reboul J, et al. Among authors: liblau r. J Neuroimmunol. 2000 Jan 3;102(1):107-12. doi: 10.1016/s0165-5728(99)00158-7. J Neuroimmunol. 2000. PMID: 10626674
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility.
Couturier N, Bucciarelli F, Nurtdinov RN, Debouverie M, Lebrun-Frenay C, Defer G, Moreau T, Confavreux C, Vukusic S, Cournu-Rebeix I, Goertsches RH, Zettl UK, Comabella M, Montalban X, Rieckmann P, Weber F, Müller-Myhsok B, Edan G, Fontaine B, Mars LT, Saoudi A, Oksenberg JR, Clanet M, Liblau RS, Brassat D. Couturier N, et al. Among authors: liblau rs. Brain. 2011 Mar;134(Pt 3):693-703. doi: 10.1093/brain/awr010. Brain. 2011. PMID: 21354972
Neurons as targets for T cells in the nervous system.
Liblau RS, Gonzalez-Dunia D, Wiendl H, Zipp F. Liblau RS, et al. Trends Neurosci. 2013 Jun;36(6):315-24. doi: 10.1016/j.tins.2013.01.008. Epub 2013 Mar 13. Trends Neurosci. 2013. PMID: 23478065 Review.
[Editorial].
Antoine JC, Liblau R, Lubetzki C. Antoine JC, et al. Among authors: liblau r. Rev Neurol (Paris). 2014 Oct;170(10):559-60. doi: 10.1016/j.neurol.2014.09.001. Rev Neurol (Paris). 2014. PMID: 25280980 French. No abstract available.
236 results